Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

MYGN Q2 2016 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$454M

Q2 2016 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$187M

Gross Profit

$147M78.6% margin

Operating Income

$36M19.1% margin

Net Income

$23M12.5% margin

EPS (Diluted)

$0.32

QoQ Revenue Growth

-2.1%

Cash Flow

Operating Cash Flow

$56M

Free Cash Flow

$54M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$881M

Total Liabilities

$132M

Stockholders' Equity

$748M

Cash & Equivalents

$69M

Revenue Segments

Diagnostics

$174M93%

Other Segments

$13M7%

← FY 2016 All Quarters Q3 2016 →